• Which ASX ETFs are good options for a $1,000 investment?

    Australian dollar notes in the pocket of a man's jeans, symbolising dividends.

    A $1,000 investment can be a strong starting point on the ASX.

    The right exchange traded fund (ETF) can spread that money across dozens, hundreds, or even thousands of companies in a single trade.

    That makes ETFs useful for investors who want diversification, long-term growth, and a simple way to get started.

    With that in mind, here are three ASX ETFs that could be good options for a $1,000 investment.

    Betashares Global Cybersecurity ETF (ASX: HACK)

    The Betashares Global Cybersecurity ETF gives investors exposure to one of the unavoidable costs of doing business in a digital world.

    Every company with customer data, online payments, cloud software, connected devices, or remote workers needs to think about cyber protection.

    That is what makes cybersecurity such an interesting long-term theme. It is not tied only to one product cycle or one fashionable technology. It is linked to the basic need to keep systems, identities, money, and information safe.

    The fund owns companies that sit close to that problem, including CrowdStrike (NASDAQ: CRWD), Palo Alto Networks (NASDAQ: PANW), and Fortinet (NASDAQ: FTNT).

    A $1,000 investment in this ETF is essentially a bet that digital risk will keep growing and that businesses will continue spending money to defend themselves.

    The fund can be volatile because it is concentrated in a specialist sector. But for investors wanting targeted exposure to cybersecurity, it could be a compelling long-term option.

    VanEck Morningstar Wide Moat ETF (ASX: MOAT)

    The VanEck Morningstar Wide Moat ETF takes a different approach.

    This fund is built around the idea that some businesses have stronger defences than others. Those defences might come from brand strength, customer relationships, cost advantages, patents, scale, or products that are difficult to replace.

    The important part is that the fund is not simply buying the largest US companies by default. It is looking for businesses that combine competitive strength with valuation discipline.

    Current holdings include NXP Semiconductors (NASDAQ: NXPI), Masco Corp (NYSE: MAS), and Airbnb (NASDAQ: ABNB).

    That mix is quite different from a standard market-cap weighted US index. It gives investors exposure to companies from different industries, but with a shared focus on business quality and durability.

    For a $1,000 investment, this ETF could suit someone who wants US exposure with a more selective investment process behind it.

    Vanguard MSCI Index International Shares ETF (ASX: VGS)

    A third ASX ETF to consider is the Vanguard MSCI Index International Shares ETF.

    This fund gives investors broad exposure to developed share markets outside Australia.

    That can be useful because many Australian portfolios are naturally tilted toward local banks, miners, supermarkets, and dividend shares. The Vanguard MSCI Index International Shares ETF expands the opportunity by adding access to companies listed in the United States, Europe, Japan, and other major developed markets.

    Its holdings include global giants such as NVIDIA (NASDAQ: NVDA), Apple (NASDAQ: AAPL), and Microsoft (NASDAQ: MSFT).

    The fund is not trying to be clever or thematic. Its strength is breadth. Investors get exposure to a very large group of international companies, which can help reduce reliance on the Australian market alone.

    For someone investing $1,000 and wanting a simple global foundation, it could be one of the easiest options on the ASX.

    The post Which ASX ETFs are good options for a $1,000 investment? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in BetaShares Global Cybersecurity ETF right now?

    Before you buy BetaShares Global Cybersecurity ETF shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and BetaShares Global Cybersecurity ETF wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has positions in VanEck Morningstar Wide Moat ETF. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Airbnb, Apple, BetaShares Global Cybersecurity ETF, CrowdStrike, Fortinet, Microsoft, NXP Semiconductors, and Nvidia. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Masco and Palo Alto Networks. The Motley Fool Australia has recommended Airbnb, Apple, CrowdStrike, Microsoft, Nvidia, VanEck Morningstar Wide Moat ETF, and Vanguard Msci Index International Shares ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • This ASX healthcare stock just got a big upgrade following capital raise

    Beautiful young woman drinking fresh orange juice in kitchen.

    ASX healthcare stock Vitrafy Life Sciences Ltd (ASX: VFY) has been one of the hottest shares in 2026. 

    The company has designed and developed an innovative solution to advance cryopreservation, including smart devices, a quality management software platform, and smart packaging solutions.

    Commercial success has led to significant share price gains of almost 150% in 2026 alone. 

    A new report from Bell Potter suggests this is likely to continue, with the broker significantly increasing its 12-month price target. 

    $30 million capital raise

    Vitrafy recently raised $30 million from institutional investors at $2.60 per share.

    Following this, the company announced a Share Purchase Plan (SPP). 

    The company said the SPP intends to raise up to $2 million. 

    The SPP provides Eligible Shareholders with the opportunity to acquire new fully paid ordinary shares in the Company (“New Shares”) at the same price as the institutional placement announced to the ASX on Friday, 12 June 2026, which raised A$30 million.

    Each Eligible Shareholder may apply for up to A$30,000 worth of New Shares at the offer price of A$2.60 per New Share, irrespective of the size of their holding in Vitrafy, without incurring brokerage or transaction costs.

    What is Bell Potter’s view?

    Following this announcement, the team at Bell Potter provided updated guidance on this ASX healthcare stock. 

    The broker largely appears constructive/bullish on the capital raise, viewing it as growth funding rather than a rescue financing.

    According to the report, commercial traction is improving, with positive developments in military blood studies, animal reproduction partnerships, and growing interest from the U.S. civilian blood market.

    The $32 million total raise (A$30m placement + A$2m SPP) provides enough capital to manufacture approximately 100 units and accelerate commercial deployment. 

    Bell Potter estimates those units could generate around A$12 million of annual managed-service revenue, plus recurring consumable sales.

    Target price increase for ASX healthcare stock

    This ASX healthcare stock closed trading yesterday at $3.19 per share. 

    The team at Bell Potter have now upgraded their 12-month price target to $5.15 (previously $3.00). 

    It has retained its speculative buy recommendation. 

    This indicates an upside potential of 61% from current levels. 

    The capital raising and developments in the Red Blood Cell market have instigated a revision to our estimates, particularly from FY28 on the revenue line, where we see 175 total units being installed by FY30 which could generate $80m in annual revenue.

    We still anticipate VFY reaching breakeven by FY30.

    The post This ASX healthcare stock just got a big upgrade following capital raise appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Vitrafy Life Sciences right now?

    Before you buy Vitrafy Life Sciences shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Vitrafy Life Sciences wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • There are still some well-priced ASX dividend shares. Here’s where to look

    View of a business man's hand passing a $100 note to another with a bank in the background.

    Chasing dividend yield at any price is a mistake.

    A high yield sitting on top of a deteriorating business is rarely worth the risk.

    The better approach is to find quality businesses that have pulled back enough to make their dividend yield attractive again.

    These three well-known ASX dividend shares fit that description right now.

    Wesfarmers Ltd (ASX: WES)

    Wesfarmers is down about 9% from the all-time high of $95.18 it set in August last year.

    That pullback has not been driven by a deteriorating business.

    In the first half of FY2026, Wesfarmers delivered net profit after tax of $1.603 billion, up 9.3% on the prior corresponding period. Reassuringly, Bunnings and Kmart both continue to deliver strong sales growth.

    The board lifted its fully franked interim dividend by 7.4% to $1.02 per share, a clear signal of confidence in the underlying cash generation.

    At the lower share price, that growing dividend now goes further.

    CMC Invest forecasts an annual dividend of $2.20 per share for FY2026, implying a forward yield of approximately 2.54%. That figure is expected to climb further as the dividend continues to grow into FY2027.

    Wesfarmers has increased its dividend every year since divesting Coles in 2020. This streak gives income investors a degree of confidence in the trajectory of consistent dividend compounding.

    BHP Group Ltd (ASX: BHP)

    BHP offers a higher starting yield than Wesfarmers, backed by one of the strongest commodity tailwinds on the ASX.

    BHP’s dividend is highly cyclical, swinging from $4.63 per share in 2022 to just $1.71 per share in 2025, before the trend reversed with a 2026 interim dividend of $1.04 per share, a healthy rise over the prior year’s 79 cents.

    Including the September final dividend, BHP currently has a trailing 12-month payout of $1.96 per share. This is fully franked, putting the trailing yield at approximately 3.3% at current prices.

    For Australian taxpayers, the full franking on that yield is important. This effectively lifts the after-tax return well above the headline figure for shareholders in the 30% tax bracket. What’s more, the franking lifts the after-tax return even further for those in pension-phase superannuation accounts able to claim the full cash refund.

    The dividend backdrop has been reinforced by BHP’s copper exposure, with copper earnings now exceeding iron ore contributions for the first time in the company’s history. This comes as demand for AI data centres and electrification drives the copper price to record levels.

    This tailwind gives the BHP dividend more support than its historical cyclicality alone would suggest.

    Telstra Group Ltd (ASX: TLS)

    Telstra is the most defensive of the three, and its dividend track record reflects that.

    Shareholders have not seen a dividend cut since 2019 and have enjoyed an annual dividend increase every year since 2022.

    Telstra’s most recent interim dividend came in at 9.5 cents per share, fully franked, matching the equivalent payout from 2025. This brings the trailing annual total to 19 cents per share and a trailing yield of approximately 3.7%.

    Brokers see further growth ahead. UBS forecasts Telstra paying 21 cents per share in FY2026, implying a grossed-up yield of approximately 6.2% including franking credits.

    Moreover, Morgan Stanley separately forecasts 20 cents per share with a price target implying further capital upside on top of the dividend.

    Telstra’s mobile division, the largest network in Australia, continues to underpin that earnings growth through pricing power and steady subscriber growth.

    The lesson for these ASX dividend shares

    Each of these three businesses has pulled back for reasons that are largely cyclical or sentiment-driven rather than structural.

    Wesfarmers fell on broader retail sector caution despite delivering double-digit profit growth.

    BHP’s yield swings with the commodity cycle.

    Telstra has simply continued growing its dividend through a defensive, less exciting period for the broader market.

    That combination of real earnings growth and a lower entry price is exactly what makes these ASX dividend shares well priced.

    Foolish takeaway

    Wesfarmers, BHP, and Telstra all offer a different entry point into ASX dividend shares right now.

    Wesfarmers offers the lowest starting yield but the most consistent growth track record. BHP offers a higher cyclical yield backed by a genuine structural copper tailwind. Telstra offers the most defensive earnings base and a long, uninterrupted streak of dividend growth.

    For income investors prepared to look past the headlines, all three remain well-priced options on the ASX today.

    The post There are still some well-priced ASX dividend shares. Here’s where to look appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Wesfarmers right now?

    Before you buy Wesfarmers shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Wesfarmers wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Mark Verhoeven has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Wesfarmers. The Motley Fool Australia has positions in and has recommended Telstra Group. The Motley Fool Australia has recommended BHP Group and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.